Back to results
US 5,310,550 AGranted
Method of treating thrombocytopenia using human BCDF in combination with IL-3
AssigneesAjinomoto Co., Inc., Tadamitsu Kishimoto
InventorsTadamitsu Kishimoto, Toshio Hirano, Hideo Kimura, Toshiyuki Ishibashi, Yukio Akiyama, Akira Okano
Life of this patent
Estimating the term…
Abstract
Thrombocytopenia is treated by administering a subject suffering from thrombocytopenia a composition containing human B cell differentiation activity in combination with IL-3.
Claims3
A method for treating thrombocytopenia, comprising:
- treating a subject suffering from thrombocytopenia with a composition containing a substance having human B cell differentiation activity in combination with interleukin three.
A method for treating thrombocytopenia, comprising:
- administering interleukin three to a subject suffering from thrombocytopenia, and then
- treating said subject administered interleukin three a composition containing a substance having human B cell differentiation activity.
A method of treating thrombocytopenia, comprising:
- treating a subject suffering from thrombocytopenia with a composition containing a substance having human B cell differentiation activity, and then, subsequent to said treatment, administering interleukin three to said subject.
Dependencies are inferred from the claim text.